Emmaus Life Sciences, Inc.

EMMA

Emmaus Life Sciences, Inc.

EMMA

Insider Sentiment (TTM):

Last Purchase:2024-09-16Last Sale:2023-12-20Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2020-09-30Institutional Shares Owned:57,034Shares Outstanding:4,898,719Institutional Ownership Pct.:1.16%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	3	1	2	0	1	1	1	1	2	2	3	2
Accounts Receivable Net Current	1	2	3	3	2	2	3	5	5	3	6	5
Inventory Net	2	2	2	1	1	1	2	2	2	2	2	2
Prepaid Expense And Other Assets Current	1	1	1	1	1	1	1	1	1	2	2	2
Assets Current	6	6	8	5	5	6	7	9	9	8	12	9
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	18
Operating Lease Right Of Use Asset	1	1	1	1	1	1	2	2	2	2	2	3
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	16	19	21	21	23	22	24	27	26	30	35	47
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	23	24	23	22	19	18	17	19	19	18	17	16
Operating Lease Liability Current	0	0	0	0	0	3	2	2	1	1	2	1
Other Liabilities Current	16	17	18	14	14	16	17	16	14	15	15	14
Derivative Instruments And Hedges Liabilities	0	0	0	0	0	0	0	0	0	0	0	1
Convertible Notes Payable Current	17	17	17	17	17	17	17	16	16	17	16	-
Liabilities Current	66	71	69	64	62	65	64	64	64	62	62	61
Operating Lease Liability Noncurrent	1	1	1	1	2	1	1	1	1	2	2	2
Other Liabilities Noncurrent	13	12	12	12	13	13	13	14	15	17	17	17
Liabilities	83	87	85	80	79	81	80	81	83	83	83	84
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	226	226	226	226	226	226	226	226	226	226	225	222
Receivable From Shareholders Or Affiliates For Iss…	-17	-17	-17	-17	-17	-17	-17	-17	-17	-17	-17	-
Accumulated Other Comprehensive Income Loss Net Of…	-3	-4	-3	-0	1	-3	-3	-2	-3	-2	-0	-2
Retained Earnings Accumulated Deficit	-272	-273	-270	-268	-266	-265	-263	-261	-263	-260	-256	-257
Stockholders Equity	-66	-68	-64	-59	-56	-59	-56	-54	-57	-54	-48	-36
Liabilities And Stockholders Equity	16	19	21	21	23	22	24	27	26	30	35	47
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	15	15	15	15	15	15	15	15	15	15	15	15
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	250	250	250	250	250	250	250	250	250	250	250	250
Common Stock Shares Issued	70	70	70	64	64	64	64	64	64	62	62	54
Shares Outstanding	70	70	70	64	64	64	64	64	64	62	62	54

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-11.46%	-5.82%	-13.19%	-	-	-	-	-	-
2025	36.67%	15.00%	25.00%	-23.23%	-25.94%	-40.00%	-40.67%	-35.33%	-36.00%
2024	-	-	-	1895.00%	1650.00%	1395.00%	-22.58%	5.81%	-10.97%
2023	-	-	-	-10.83%	8.33%	8.33%	-21.96%	-99.89%	-77.01%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.09	0.08	0.11	0.07	0.08	0.09	0.11	0.14	0.14	0.13	0.19	0.15
Quick Ratio	0.05	0.04	0.07	0.05	0.05	0.05	0.06	0.10	0.10	0.08	0.13	0.10
Working Capital	-60.11M	-64.54M	-61.33M	-59.38M	-57.06M	-59.26M	-56.79M	-54.93M	-55.01M	-54.58M	-50.00M	-51.66M
Leverage & Debt
Debt to Equity	-1.25	-1.28	-1.34	-1.35	-1.42	-1.38	-1.42	-1.51	-1.45	-1.55	-1.74	-2.31
Interest Coverage TTM	0.44	0.00	-0.02	-0.09	-0.08	0.08	-0.20	0.41	0.29	0.55	0.75	-0.08
Debt Ratio	5.04	4.63	3.97	3.87	3.39	3.61	3.39	2.97	3.20	2.82	2.36	1.77
Efficiency & Turnover
Asset Turnover TTM	0.92	0.72	0.68	0.72	0.79	0.84	0.75	0.83	0.81	0.92	0.97	0.73
Days Sales Outstanding TTM	27.65	50.51	64.86	79.86	62.83	42.03	67.49	55.74	60.41	26.25	26.68	33.87
Receivables Turnover TTM	13.20	7.23	5.63	4.57	5.81	8.68	5.41	6.55	6.04	13.90	13.68	10.78
Per Share Metrics
Diluted EPS TTM	-0.06	-0.14	-0.13	-0.15	-0.09	-0.10	-0.14	-0.08	-0.11	-0.10	-0.10	-0.10
Free Cash Flow Per Share TTM	0.02	-0.05	-0.05	-0.08	-0.08	-0.08	-0.08	-0.05	-0.05	-0.02	-0.05	-0.04
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	93.76%	93.60%	93.41%	93.21%	93.19%	93.57%	93.45%	94.90%	95.41%	95.35%	95.42%	93.31%
Operating Profit Margin TTM	22.78%	0.12%	-0.91%	-3.65%	-2.60%	2.04%	-5.96%	10.72%	8.29%	14.65%	17.01%	-2.06%
Net Profit Margin TTM	-39.01%	-64.88%	-56.50%	-54.85%	-28.76%	-30.18%	-39.21%	-16.21%	-22.18%	-17.14%	-13.11%	-41.63%
Growth Metrics
Net Revenue Growth (1Y)	-5.28%	-32.30%	-30.69%	-44.62%	-36.96%	-39.27%	-45.41%	-4.76%	-5.94%	37.84%	77.96%	49.06%
Net Income Growth (1Y)	28.51%	45.52%	-0.12%	87.44%	-18.26%	6.97%	63.24%	-62.93%	-51.65%	-71.12%	-72.89%	-10.29%
EPS Growth (1Y)	16.93%	32.41%	-1.37%	87.44%	-18.91%	3.58%	37.09%	-68.87%	-59.65%	-76.32%	-74.76%	-17.11%
Valuation Metrics
P/E TTM	-0.10	-0.11	-0.10	-0.07	-0.15	-0.16	-0.06	-0.38	-0.94	-1.05	-1.00	-0.49
P/B TTM	-0.01	-0.02	-0.01	-0.01	-0.01	-0.02	-0.01	-0.04	-0.11	-0.12	-0.11	-0.18
P/S TTM	0.04	0.07	0.05	0.04	0.04	0.05	0.02	0.06	0.21	0.18	0.13	0.20
Market Cap	718.03K	1.05M	832.50K	702.52K	830.25K	1.09M	537.50K	1.90M	6.41M	6.49M	5.31M	6.70M
Enterprise Value	15.24M	17.34M	16.09M	17.21M	16.75M	16.62M	16.16M	16.85M	21.21M	21.37M	19.15M	5.20M
Calculated Values
Free Cash Flow TTM	1.06M	-3.54M	-2.92M	-4.80M	-5.07M	-5.08M	-5.22M	-2.92M	-3.01M	-1.40M	-2.83M	-1.96M
Net Debt	14.53M	16.28M	15.25M	16.51M	15.92M	15.53M	15.63M	14.95M	14.80M	14.88M	13.84M	-1.51M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-09-16Purchase

Owner: Lim, Seah H.

Title: -

Shares: 20,000

Price/Share: $0.04

Value: $800.00

Shares Owned: 4,606,626

Relationship: Director

Ownership: Direct

2024-02-29Purchase

Owner: Lee, Willis C

Title: Co-President & COO

Shares: 77,000

Price/Share: $0.13

Value: $10,010.00

Shares Owned: 159,400

Relationship: Director,Officer

Ownership: Indirect

2023-12-20Sale

Owner: Lim, Seah H.

Title: -

Shares: 32,500

Price/Share: $0.05

Value: $1,625.00

Shares Owned: 4,586,626

Relationship: Director

Ownership: Direct

2023-12-15Sale

Owner: Lim, Seah H.

Title: -

Shares: 6,000

Price/Share: $0.11

Value: $660.00

Shares Owned: 171,700

Relationship: Director

Ownership: Direct

2023-11-30Purchase

Owner: Lee, Willis C

Title: COO

Shares: 7,417

Price/Share: $0.12

Value: $890.04

Shares Owned: 395,124

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-09-16	Lim, Seah H.	Director	-	Direct	Purchase	20,000	0.04	$800.00	4,606,626	4
2024-02-29	Lee, Willis C	Director,Officer	Co-President & COO	Indirect	Purchase	77,000	0.13	$10,010.00	159,400	4
2023-12-20	Lim, Seah H.	Director	-	Direct	Sale	32,500	0.05	$1,625.00	4,586,626	4
2023-12-15	Lim, Seah H.	Director	-	Direct	Sale	6,000	0.11	$660.00	171,700	4
2023-11-30	Lee, Willis C	Director,Officer	COO	Direct	Purchase	7,417	0.12	$890.04	395,124	4
2023-09-05	Lim, Seah H.	Director	-	Direct	Purchase	1,700	0.15	$255.00	177,700	4
2023-08-31	Lee, Willis C	Director,Officer	COO	Indirect	Purchase	6,000	0.15	$900.00	43,100	4/A
2023-05-31	Lee, Willis C	Director,Officer	COO	Indirect	Purchase	28,700	0.29	$8,323.00	30,600	4
2022-11-30	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	22,900	0.41	$9,389.00	12,040,857	4
2022-11-02	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	15,000	0.43	$6,450.00	11,988,257	4
2022-10-28	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	7,500	0.42	$3,150.00	11,960,757	4
2022-10-21	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	10,000	0.19	$1,900.00	11,891,357	4
2022-10-18	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	30,000	0.19	$5,700.00	11,826,357	4
2022-10-14	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	35,000	0.17	$5,950.00	11,781,357	4
2022-10-12	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	160,000	0.08	$12,800.00	11,683,857	4
2022-10-10	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	10,000	0.09	$900.00	11,388,857	4
2022-07-19	Lee, Willis C	Director,Officer	COO	Direct	Purchase	3,200	0.39	$1,248.00	286,974	4
2022-05-31	Lee, Willis C	Director,Officer	Director & COO	Direct	Purchase	2,500	0.40	$1,000.00	283,774	4
2022-05-23	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	2,000	0.50	$1,000.00	11,333,857	4
2022-05-18	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	7,351	0.35	$2,572.85	11,326,857	4
2022-04-11	Lee, Willis C	Director,Officer	Director & COO	Direct	Purchase	8,900	0.88	$7,832.00	278,774	4
2022-02-28	Lee, Willis C	Director,Officer	Vice Chairman & COO	Direct	Purchase	7,200	1.51	$10,872.00	269,874	4
2022-02-28	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	53,800	1.49	$80,162.00	11,303,506	4
2022-02-25	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	5,500	1.41	$7,755.00	11,249,706	4
2022-02-22	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	17,800	1.44	$25,632.00	11,233,206	4
2022-02-17	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	6,500	1.43	$9,295.00	11,213,906	4
2022-02-15	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	6,000	1.45	$8,700.00	11,206,406	4
2022-02-11	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	4,000	1.49	$5,960.00	11,194,406	4
2022-02-08	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	3,250	1.49	$4,842.50	11,163,906	4
2022-02-04	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	7,000	1.43	$10,010.00	11,155,406	4
2022-01-03	Lui, Alfred Fu Kong	Director	-	Direct	Purchase	10,000	1.58	$15,800.00	10,000	4
2021-12-31	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	7,000	1.58	$11,060.00	11,142,156	4
2021-12-27	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	1,200	1.48	$1,776.00	11,124,656	4
2021-12-21	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	4,900	1.49	$7,301.00	11,116,956	4
2021-12-17	Lee, Willis C	Director,Officer	Vice Chairman & COO	Indirect	Purchase	500	1.50	$750.00	1,000	4
2021-12-16	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	4,000	1.54	$6,160.00	11,106,306	4
2021-12-09	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	2,000	1.69	$3,380.00	11,096,806	4
2021-12-03	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	1,000	1.55	$1,550.00	11,090,206	4
2021-12-01	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	5,750	1.72	$9,890.00	11,085,806	4
2021-11-30	Lee, Willis C	Director,Officer	Vice Chairman & COO	Indirect	Purchase	15,500	1.50	$23,250.00	228,394	4
2021-11-29	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	16,000	1.45	$23,200.00	11,044,456	4
2021-11-24	Lee, Willis C	Director,Officer	Vice Chairman & COO	Indirect	Purchase	34,500	1.34	$46,230.00	172,861	4
2021-11-24	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	19,300	1.34	$25,862.00	10,972,447	4
2021-11-22	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	12,000	1.44	$17,280.00	10,946,147	4
2021-11-19	Lee, Willis C	Director,Officer	Vice Chairman & COO	Indirect	Purchase	5,000	1.37	$6,850.00	125,961	4
2021-11-18	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	13,000	1.28	$16,640.00	10,919,147	4
2021-10-20	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	1,000	1.57	$1,570.00	10,886,147	4
2021-10-06	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	1,000	1.52	$1,520.00	10,885,147	4
2021-09-27	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	1,000	1.64	$1,640.00	10,882,147	4
2021-09-24	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	1,000	1.70	$1,700.00	10,881,147	4
2021-09-22	Niihara, Yutaka	Director,Officer,TenPercentOwner	Chairman and CEO	Direct	Purchase	1,582	1.73	$2,736.86	10,878,647	4
2021-09-17	Lee, Willis C	Director,Officer	Vice Chairman & COO	Indirect	Purchase	500	1.71	$855.00	116,261	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2020-09-30

1.16%

Inst. Shares: 57,034

Shares Outstanding: 4,898,719

2020-03-31

Inst. Shares: -

Shares Outstanding: 4,862,447

2019-12-31

Inst. Shares: -

Shares Outstanding: 4,225,946

2019-09-30

Inst. Shares: -

Shares Outstanding: 4,600,494

2019-06-30

1.61%

Inst. Shares: 61,103

Shares Outstanding: 3,783,668

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2020-09-30	57,034	4,898,719	1.16%
2020-03-31	0	4,862,447	-
2019-12-31	0	4,225,946	-
2019-09-30	0	4,600,494	-
2019-06-30	61,103	3,783,668	1.61%
2019-03-31	51,122	3,747,343	1.36%
2018-12-31	127,907	3,747,343	3.41%
2018-09-30	93,203	740,725	12.58%
2018-06-30	109,033	626,160	17.41%
2018-03-31	39,964	436,431	9.16%
2017-12-31	40,400	436,056	9.26%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Emmaus Life Sciences, Inc. (EMMA) — SEC Financial Statements & Analysis

Emmaus Life Sciences, Inc. (EMMA) is a pharmaceutical preparations company, incorporated in DE. Emmaus Life Sciences, Inc. trades on OTC as: EMMA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Emmaus Life Sciences, Inc. reported a -5.28% year-over-year revenue growth, a Gross Profit Margin of 93.76% (TTM), a Debt-to-Equity ratio of -1.25x, a Price-to-Sales (P/S) ratio of 0.04x (TTM), a Price-to-Book (P/B) ratio of -0.01x (TTM), at a market cap of $718.03K. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -5.28%
Gross Profit Margin TTM: 93.76%
Debt To Equity: -1.25x
P/S TTM: 0.04x
P/B TTM: -0.01x
Market Cap: $718.03K

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Emmaus Life Sciences, Inc. in?

Emmaus Life Sciences, Inc. (EMMA) operates in the Pharmaceutical Preparations industry.

What is EMMA's market cap?

Emmaus Life Sciences, Inc. (EMMA) has a market capitalization of $718.03K as of 2026-06-30.

What exchange does EMMA trade on?

Emmaus Life Sciences, Inc. (EMMA) trades on the OTC.

Where is Emmaus Life Sciences, Inc. incorporated?

Emmaus Life Sciences, Inc. is incorporated in DE.